What is Aviva Research?
Aviva Research is a dedicated provider of meticulous, accurate, and efficient research services tailored for pharmaceutical companies. The company emphasizes the development of organic relationships with its sponsors and the community to streamline data acquisition and enhance study safety. A core tenet of Aviva Research's philosophy is the critical role of patient satisfaction, happiness, and pro-activeness in study success. By committing significant resources to patient engagement, Aviva Research aims to be at the forefront of clinical trials, contributing to the advancement of treatments for diseases and maladies with the highest degree of professionalism.
How much funding has Aviva Research raised?
Aviva Research has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
What's next for Aviva Research?
The substantial expansion capital secured by Aviva Research at its Series B/C stage indicates a strategic pivot towards scaling operations and potentially broadening its research capabilities. This financing is likely to fuel advancements in patient engagement technologies and data management systems, further solidifying its position in the competitive clinical trials landscape. Future growth may involve expanding service offerings to a wider range of pharmaceutical partners or investing in novel research methodologies to accelerate drug development pipelines.
See full Aviva Research company page
